NCT03015038View on ClinicalTrials.gov

Study of the Immune Response in Colon Adenocarcinoma

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

February 5, 2017

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions

Colon Adenocarcinoma

Trial Locations (1)

75000

Hôpital Saint Louis, Paris

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Innate Pharma

INDUSTRY

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV